tradingkey.logo

Forian Inc

FORA
查看詳細走勢圖
2.090USD
-0.005-0.24%
收盤 02/06, 16:00美東報價延遲15分鐘
64.78M總市值
虧損本益比TTM

Forian Inc

2.090
-0.005-0.24%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.24%

5天

-0.48%

1月

-1.88%

6月

+9.41%

今年開始到現在

-1.42%

1年

-12.92%

查看詳細走勢圖

TradingKey Forian Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Forian Inc當前公司基本面數據相對非常健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在軟體與IT服務行業排名159/482位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為2.10。中期看,股價處於平穩狀態。近一個月,市場表現一般,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Forian Inc評分

相關信息

行業排名
159 / 482
全市場排名
268 / 4521
所屬行業
軟體與IT服務

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Forian Inc亮點

亮點風險
Forian Inc. is a healthtech company. The Company is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The Company provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.
業績增長期
公司處於發展階段,最新年度總收入20.15M美元
業績轉虧
公司業績轉虧,最新年度虧損美元
估值低估
公司最新PE估值-76.42,處於3年歷史低位
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉58.80K股
活躍度增加
近期活躍度增加,過去20天平均換手率2.36

分析師目標

基於 1 分析師
持有
評級
2.100
目標均價
+0.24%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Forian Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Forian Inc簡介

Forian Inc. is a healthtech company. The Company is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The Company provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. It has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.
公司代碼FORA
公司Forian Inc
CEOWygod (Max)
網址https://forian.com/
KeyAI